Title | Type | SJR | H index | Total Docs. (2016) | Total Docs. (3years) | Total Refs. (2016) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2016) | %Female (2016) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
85 | Advances in Pharmacology | journal | 1.526 Q1 | 86 | 39 | 119 | 5476 | 463 | 0 | 3.76 | 140.41 | 0.00 | |
84 | Cannabis and Cannabinoid Research | journal | 42 | 35 | 0 | 1457 | 0 | 0 | 0.00 | 41.63 | 46.15 | ||
83 | Profiles of Drug Substances, Excipients and Related Methodology | journal | 0.236 Q3 | 29 | 6 | 30 | 995 | 46 | 0 | 1.44 | 165.83 | 0.00 | |
82 | National Toxicology Program technical report series | journal | 0.131 | 22 | 0 | 4 | 0 | 4 | 4 | 0.00 | 0.00 | 0.00 | |
81 | Journal of Applied Research | journal | 0.161 Q4 | 23 | 0 | 6 | 0 | 1 | 6 | 0.00 | 0.00 | 0.00 | |
80 | Contemporary Clinical Trials Communications | journal | 0.154 Q4 | 26 | 70 | 9 | 2175 | 2 | 7 | 0.22 | 31.07 | 53.85 | |
79 | Neuropsychopharmacology Reports | journal | 22 | 1 | 12 | 0 | 0 | 12 | 0.00 | 0.00 | 0.00 | ||
78 | Cancer Therapy | journal | 0.135 Q4 | 9 | 0 | 13 | 0 | 3 | 13 | 0.00 | 0.00 | 0.00 | |
77 | Psychopharm Review | trade journal | 0.146 Q4 | 5 | 0 | 14 | 0 | 3 | 14 | 0.00 | 0.00 | 0.00 | |
76 | Adverse Drug Reaction Bulletin | journal | 0.105 Q4 | 8 | 5 | 18 | 217 | 4 | 18 | 0.17 | 43.40 | 25.00 | |
75 | Clinical Research and Regulatory Affairs | journal | 0.404 Q3 | 18 | 8 | 29 | 289 | 38 | 29 | 1.76 | 36.13 | 60.00 | |
74 | Drug Resistance Updates | journal | 3.794 Q1 | 132 | 31 | 41 | 5374 | 454 | 41 | 12.10 | 173.35 | 40.46 | |
73 | Pharmacopeial Forum (discontinued) | journal | 0.191 Q4 | 20 | 14 | 44 | 216 | 16 | 44 | 0.41 | 15.43 | 24.29 | |
72 | Critical Reviews in Therapeutic Drug Carrier Systems | journal | 0.706 Q2 | 82 | 14 | 45 | 2887 | 315 | 45 | 7.00 | 206.21 | 34.88 | |
71 | Current Protocols in Pharmacology | journal | 0.620 Q2 | 39 | 17 | 51 | 863 | 102 | 51 | 1.84 | 50.76 | 33.33 | |
70 | Journal of Experimental Therapeutics and Oncology | journal | 0.273 Q3 | 40 | 25 | 51 | 567 | 46 | 51 | 0.68 | 22.68 | 28.16 | |
69 | Topics in antiviral medicine | journal | 1.493 Q1 | 46 | 17 | 58 | 356 | 216 | 55 | 3.21 | 20.94 | 38.24 | |
68 | Drug Topics | journal | 0.100 Q4 | 8 | 263 | 799 | 21 | 2 | 65 | 0.00 | 0.08 | 46.15 | |
67 | Food and Drug Law Journal | journal | 0.263 Q3 | 23 | 21 | 75 | 1282 | 53 | 73 | 0.80 | 61.05 | 40.63 | |
66 | Annual Review of Pharmacology and Toxicology | journal | 8.284 Q1 | 224 | 31 | 87 | 3850 | 1380 | 85 | 13.47 | 124.19 | 38.82 | |
65 | Current Therapeutic Research | journal | 0.776 Q2 | 46 | 7 | 94 | 143 | 287 | 90 | 3.15 | 20.43 | 15.38 | |
64 | Pharmacological Reviews | journal | 8.051 Q1 | 254 | 26 | 94 | 10565 | 1986 | 94 | 20.57 | 406.35 | 33.01 | |
63 | Human gene therapy methods | journal | 0.885 Q2 | 38 | 24 | 103 | 794 | 220 | 101 | 1.97 | 33.08 | 32.59 | |
62 | Journal of Herbs, Spices and Medicinal Plants | journal | 0.204 Q3 | 34 | 29 | 105 | 890 | 52 | 105 | 0.50 | 30.69 | 38.10 | |
61 | Medicinal Research Reviews | journal | 2.701 Q1 | 150 | 33 | 111 | 6234 | 1030 | 111 | 9.20 | 188.91 | 38.22 | |
60 | Medical Letter on Drugs and Therapeutics | journal | 0.429 Q3 | 22 | 135 | 331 | 913 | 161 | 124 | 0.53 | 6.76 | 0.00 | |
59 | Prostaglandins and Other Lipid Mediators | journal | 1.341 Q1 | 86 | 46 | 148 | 2674 | 458 | 142 | 2.71 | 58.13 | 43.92 | |
58 | Journal of Immunotherapy | journal | 2.110 Q1 | 106 | 44 | 149 | 1983 | 698 | 145 | 4.24 | 45.07 | 37.50 | |
57 | Journal of Pharmacokinetics and Pharmacodynamics | journal | 0.714 Q2 | 70 | 44 | 161 | 1690 | 317 | 156 | 1.74 | 38.41 | 31.41 | |
56 | Clinical Neuropharmacology | journal | 0.637 Q2 | 85 | 76 | 163 | 2160 | 323 | 157 | 1.70 | 28.42 | 36.50 | |
55 | Experimental and Clinical Psychopharmacology | journal | 1.275 Q1 | 101 | 47 | 170 | 3081 | 431 | 167 | 2.45 | 65.55 | 50.26 | |
54 | Drug and Chemical Toxicology | journal | 0.542 Q3 | 54 | 68 | 188 | 2733 | 320 | 186 | 1.67 | 40.19 | 40.92 | |
53 | Biologicals | journal | 0.648 Q2 | 66 | 77 | 192 | 2357 | 357 | 189 | 1.93 | 30.61 | 34.71 | |
52 | Current Cardiovascular Risk Reports | journal | 0.475 Q3 | 34 | 44 | 190 | 2606 | 172 | 190 | 0.92 | 59.23 | 46.09 | |
51 | Cancer Biotherapy and Radiopharmaceuticals | journal | 0.694 Q2 | 68 | 48 | 217 | 1603 | 441 | 213 | 1.71 | 33.40 | 34.87 | |
50 | Reading Teacher | journal | 0.470 Q3 | 60 | 94 | 249 | 2039 | 204 | 221 | 0.77 | 21.69 | 79.86 | |
49 | Journal of NeuroImmune Pharmacology | journal | 1.774 Q1 | 91 | 66 | 229 | 3958 | 965 | 222 | 3.41 | 59.97 | 45.48 | |
48 | Journal of Pharmacological and Toxicological Methods | journal | 0.795 Q2 | 83 | 89 | 228 | 3896 | 640 | 223 | 2.52 | 43.78 | 35.22 | |
47 | International Journal of Medicinal Mushrooms | journal | 0.408 Q3 | 41 | 112 | 227 | 3597 | 396 | 226 | 1.60 | 32.12 | 42.59 | |
46 | Behavioural Pharmacology | journal | 1.014 Q2 | 87 | 92 | 239 | 4945 | 584 | 234 | 2.41 | 53.75 | 44.11 | |
45 | Microbial Drug Resistance | journal | 1.015 Q2 | 78 | 96 | 261 | 3569 | 663 | 247 | 2.48 | 37.18 | 48.29 | |
44 | Journal of Biopharmaceutical Statistics | journal | 0.609 Q3 | 56 | 84 | 259 | 2098 | 235 | 249 | 1.06 | 24.98 | 30.90 | |
43 | Vascular Pharmacology | journal | 1.247 Q1 | 108 | 126 | 261 | 7703 | 923 | 252 | 3.68 | 61.13 | 43.07 | |
42 | Pharmacy Times | trade journal | 0.117 Q4 | 8 | 240 | 884 | 1054 | 18 | 265 | 0.02 | 4.39 | 60.47 | |
41 | Addiction Biology | journal | 2.296 Q1 | 93 | 100 | 296 | 5735 | 1378 | 294 | 4.31 | 57.35 | 44.92 | |
40 | Journal of the American Pharmacists Association : JAPhA | journal | 0.506 Q3 | 73 | 127 | 350 | 2177 | 376 | 308 | 0.85 | 17.14 | 58.45 | |
39 | Bulletin of Mathematical Biology | journal | 0.682 Q2 | 97 | 91 | 331 | 3971 | 517 | 323 | 1.44 | 43.64 | 31.54 | |
38 | Pharmacology and Therapeutics | journal | 4.450 Q1 | 233 | 131 | 331 | 24955 | 4010 | 330 | 11.62 | 190.50 | 40.04 | |
37 | Journal of Ocular Pharmacology and Therapeutics | journal | 0.685 Q2 | 72 | 104 | 364 | 3403 | 697 | 336 | 1.73 | 32.72 | 34.88 | |
36 | American Journal of Therapeutics | journal | 0.430 Q3 | 69 | 336 | 366 | 8856 | 396 | 340 | 1.17 | 26.36 | 33.16 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®